FindTrial
Sign In

Comparison of the effects in illness evaluating of different diagnostic criteria (ISTH, JAAM, JMHW, CDSS) for disseminated intravascular coagulation in patients with sepsis

Comparison of the effects in illness evaluating of different diagnostic criteria (ISTH, JAAM, JMHW, CDSS) for disseminated intravascular coagulation in patients with sepsis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100050527
Enrollment
Unknown
Registered
2021-08-28
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sepsis

Interventions

Case series:none

Sponsors

Zhongshan Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years; 2. Patients who meet the sepsis 3.0 standard proposed by the international consensus of sepsis experts in 2016.

Exclusion criteria

Exclusion criteria: 1. Pregnancy, perinatal period, traumatic history and toxicosis before onset; 2. Thrombotic thrombocytopenic purpura (TTP), antiphospholipid syndrome (APS) and heparin-induced thrombocytopenia (HIT); History of thrombosis (antithrombin deficiency, protein S deficiency, protein C deficiency); 3. Child-Pugh C liver cirrhosis, received anticoagulation therapy (warfarin, dabigatran, rivaroxaban).

Design outcomes

Primary

MeasureTime frame
disseminated intravascular coagulation Positive rate;—

Secondary

MeasureTime frame
mortality for 28 days;multiple organ failure;—

Countries

China

Contacts

Public ContactShao Mian

Zhongshan Hospital Fudan University

shao.mian@zs-hospital.sh.cn+86 15026579625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026